Cordis’ S.M.A.R.T. Radianz Transradial Vascular Stent System Approved by FDA

March 10, 2022—Cordis announced that the FDA has approved the SMART Radianz vascular stent system, a self-expanding stent for radial peripheral procedures.

The device is designed to facilitate the accurate, efficient placement of stents in the iliac artery and superficial femoral artery (SFA). The product is available in a broad size matrix to support iliac and SFA lesion treatment.

The SMART Radianz joins the Brite Tip Radianz guiding sheath and Saberx Radianz percutaneous transluminal angioplasty catheter to complete the Radianz radial peripheral system.

According to Cordis, the SMART Radianz vascular stent system’s ergonomics and one-handed deployment capability provide placement accuracy and stability. The rapid exchange delivery system offers convenient wire management and device exchange.

“I am excited that Cordis has committed to delivering new interventional tools that can be utilized in treating patients with cardiac or vascular disorders via a transradial access,” commented Craig M. Walker, MD, in the company’s press release.

Dr. Walker, who is President and Founder of the Cardiovascular Institute of the South in Houma, Louisiana, continued, “We have been constrained in the greater utilization of this important access site associated with greater patient comfort and less major bleeding as our diagnostic and interventional tools that can be delivered via this access have been limited. These lower-profile devices should expand the utilization of radial access in treating patients.”